finance
Castle Biosciences Reports Steady Start to Fiscal Year 2026
Castle Biosciences, a prominent molecular diagnostics company, has released its financial outcomes for the initial quarter of 2026. The report details the firm
5/12/2026, 12:15:54 PM
Castle Biosciences, Inc. has announced its financial performance for the first quarter of fiscal year 2026, indicating a period of consistent activity. According to